drugset
drugset / Trial / NCT03113851

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

NCT03113851 ↗

Phase 2 Completed 40 enrolled Peking University Cancer Hospital & Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether radiation combined with recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF) is safe and effective for patients with metastatic non-small cell lung cancer.

Timeline

Start
2017-08-14
Primary completion
2018-08-14
Completion
2018-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject rhGM-CSF Protein / enzyme biologic 125 mg/m2 Subcutaneous

Indications

lung cancer